FR EA

Extract to table

Pull the structured facts out of a document: parties, dates, amounts, obligations.

Extract to table / form-906-closing-agreement-executed.docx
form-906-closing-agreement-executed.docx · 1018-00009

Parties

Penterra Pharmaceuticals Corp
Federal Inc
United States Corporation Inc
Harkness LLP
Applicable Corp
Whitmore Valuation Group LLC
Taxable Inc
Because Penterra Pharmaceuticals Corp

Dates

March 29, 2024
December 31, 2017
December 31, 2018
December 31, 2019
December 31, 2020
June 1, 2022
June 8, 2022
May 16, 2022
July 1, 2012
December 31, 2012

Amounts

$312,000,000
$42,650,000
$235,010,000
$188,040,000
$380,400,000
$79,884,000
$15,976,800
$15,977,000
$15,980,000
$47,600,000

Obligations

This agreement is final and conclusive as to the specific matters covered herein, and, except upon a showing of fraud, malfeasance, or misrepresentation of a material fact, the matters agreed to herein shall not be reopened or modified by either party
(EIN: 22-3741856), as reported on its Forms 1120 for the taxable years specified below, shall be increased by the following amounts
Payment shall be made by electronic funds transfer to the United States Treasury, referencing EIN 22-3741856 and the applicable taxable years
4 — Penalties The IRC § 6662(e) substantial valuation misstatement penalty in the amount of Fifteen Million Nine Hundred Seventy-Seven Thousand Dollars ($15,977,000) (approximately $15,980,000), as originally proposed by the Commissioner in the Notice of Proposed Adjustment dated October 12, 2023, is hereby fully abated and shall not be asserted or assessed against the taxpayer for any of the taxable years at issue
The taxpayer retains the right to seek relief from double taxation through the competent authority process, and the Commissioner agrees to cooperate in any such process in accordance with applicable law and treaty obligations
Nothing in this agreement shall be construed as an admission by either party regarding the correctness or incorrectness of any position taken during the examination or Appeals proceedings